Tag: GCP compliance

Integrating Transition/Exit Plans & Knowledge Transfer With QMS, Risk Registers and Governance Committees Integrating Transition/Exit Plans & Knowledge Transfer With QMS, Risk Registers and Governance Committees The clinical trial environment is characterized by a dynamic landscape where various stakeholders—including sponsor organizations, contract research organizations (CROs), and clinical research labs—must effectively manage transitions and exits to…

Read More “Integrating Transition/Exit Plans & Knowledge Transfer With QMS, Risk Registers and Governance Committees” »

Future-Proofing Transition/Exit Plans & Knowledge Transfer for AI, Real-World Data and Platform Trials In the evolving landscape of clinical trials, particularly those conducting nida clinical trials, organizations must establish robust transition and exit plans to navigate the complexities of vendor oversight and outsourcing. This guide offers a comprehensive approach for clinical operations, regulatory affairs, and…

Read More “Future-Proofing Transition/Exit Plans & Knowledge Transfer for AI, Real-World Data and Platform Trials” »

Aligning Transition/Exit Plans & Knowledge Transfer With ICH E6(R3), GCP and Quality-by-Design Principles Aligning Transition/Exit Plans & Knowledge Transfer With ICH E6(R3), GCP and Quality-by-Design Principles In the clinical trial landscape, the evolution of methodologies and regulations has underscored the necessity to properly manage transition and exit plans along with knowledge transfer protocols. This article…

Read More “Aligning Transition/Exit Plans & Knowledge Transfer With ICH E6(R3), GCP and Quality-by-Design Principles” »

Transition and Exit Plans for Clinical Operations and Vendor Governance Teams In the dynamic field of clinical research, the need for efficient transition and exit strategies in clinical trials is imperative for maintaining compliance and operational continuity. This article provides a detailed step-by-step guide aimed at clinical operations, regulatory affairs, and medical affairs professionals in…

Read More “Transition/Exit Plans & Knowledge Transfer Checklists for Clinical Operations and Vendor Governance Teams” »

Common Pitfalls in Transition/Exit Plans & Knowledge Transfer—and How to Avoid Regulatory Findings Common Pitfalls in Transition/Exit Plans & Knowledge Transfer—and How to Avoid Regulatory Findings The complexity of clinical trials necessitates robust planning at every stage, particularly during transitions and exits. These critical phases not only involve logistical considerations but also the safeguarding of…

Read More “Common Pitfalls in Transition/Exit Plans & Knowledge Transfer—and How to Avoid Regulatory Findings” »

Using KPIs and SLAs to Optimize Transition/Exit Plans & Knowledge Transfer Across CROs and Service Providers Using KPIs and SLAs to Optimize Transition/Exit Plans & Knowledge Transfer Across CROs and Service Providers The landscape of clinical trials is evolving, with a notable demand for effective vendor oversight and outsourcing strategies. This complexity increases with the…

Read More “Using KPIs and SLAs to Optimize Transition/Exit Plans & Knowledge Transfer Across CROs and Service Providers” »

Transition/Exit Plans & Knowledge Transfer for Decentralized, Hybrid and Data-Heavy Clinical Trials Transition/Exit Plans & Knowledge Transfer for Decentralized, Hybrid and Data-Heavy Clinical Trials The landscape of clinical research is rapidly evolving with the increasing adoption of decentralized and hybrid models. This shift emphasizes the importance of effective transition and exit plans, as well as…

Read More “Transition/Exit Plans & Knowledge Transfer for Decentralized, Hybrid and Data-Heavy Clinical Trials” »

Transition/Exit Plans & Knowledge Transfer: Clinical Trial Outsourcing Blueprint for Sponsors and Biotechs Transition/Exit Plans & Knowledge Transfer: Clinical Trial Outsourcing Blueprint for Sponsors and Biotechs Introduction to Clinical Trial Outsourcing The process of clinical trial outsourcing has become a significant strategy for sponsors and biotechs aiming for operational efficiency in a competitive regulatory landscape….

Read More “Transition/Exit Plans & Knowledge Transfer: Clinical Trial Outsourcing Blueprint for Sponsors and Biotechs” »

How to Design Transition/Exit Plans & Knowledge Transfer for Global GCP-Compliant Clinical Programs How to Design Transition/Exit Plans & Knowledge Transfer for Global GCP-Compliant Clinical Programs In the landscape of clinical research, the ability to efficiently manage transitions and knowledge transfer between different phases and stakeholders is critical. This guide is tailored for clinical operations,…

Read More “How to Design Transition/Exit Plans & Knowledge Transfer for Global GCP-Compliant Clinical Programs” »

Transition/Exit Plans & Knowledge Transfer in Clinical Trials: Best Practices for US, UK and EU Markets Transition/Exit Plans & Knowledge Transfer in Clinical Trials: Best Practices for US, UK and EU Markets Clinical trials serve as a critical component in the development of new treatments, particularly for conditions such as ovarian cancer and various other…

Read More “Transition/Exit Plans & Knowledge Transfer in Clinical Trials: Best Practices for US, UK and EU Markets” »